Literature DB >> 28511494

Eyelid Malignancies- Always Quite Challenging.

Arumugham Balasubramanian1, Narayanasamy Subbaraju Kannan2.   

Abstract

The diagnosis and management of eyelid cancers are quite challenging. Eyelid tumours are relatively rare diverse group of diseases varied in their presentation and extent. Many benign tumours and inflammatory conditions quite frequently masquerade eyelid cancers. Eyelid cancers are not single entity but comprise a wide range of tumours with extremes of tumour biology from indolent to very aggressive histopathologic types. Compromise on aesthetics and eyelids' indispensable function of protecting the eyes during management, may lead to untoward cosmetic disfigurement and loss of vision. On the other hand, inadequate cancer clearance will also be vision threatening and life threatening due to loco regional recurrence and metastasis. To strike an optimal balance is a challenging task, to achieve 'cancer cure' with maximum preservation of function and cosmetics. In addition, the integration of other modalities of treatment, judicious selection and their sequencing require multidisciplinary discussion and joint management by different specialists. We are presenting four case scenarios, we met with in our teaching hospital with reference to literature review to emphasize that eyelid malignancies are not always simple with respect to diagnosis and management.

Entities:  

Keywords:  Adjuvant radiotherapy; Moh’s micrographic surgery; Neoadjuvant chemotherapy; Ocular adnexal cancers

Year:  2017        PMID: 28511494      PMCID: PMC5427420          DOI: 10.7860/JCDR/2017/23695.9582

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  23 in total

1.  Efficacy of narrow-margin excision of well-demarcated primary facial basal cell carcinomas.

Authors:  Arash Kimyai-Asadi; Murad Alam; Leonard H Goldberg; S Ray Peterson; Sirunya Silapunt; Ming H Jih
Journal:  J Am Acad Dermatol       Date:  2005-09       Impact factor: 11.527

Review 2.  Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update.

Authors:  B E Cook; G B Bartley
Journal:  Ophthalmology       Date:  2001-11       Impact factor: 12.079

3.  Evaluation of 48 cases of orbital exenteration.

Authors:  J E Rathbun; C Beard; M H Quickert
Journal:  Am J Ophthalmol       Date:  1971-07-30       Impact factor: 5.258

4.  Incidence of eyelid cancers in Singapore from 1968 to 1995.

Authors:  S B Lee; S M Saw; K G Au Eong; T K Chan; H P Lee
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

5.  Orbital exenteration: one size does not fit all.

Authors:  Guy J Ben Simon; Robert M Schwarcz; Raymond Douglas; Danica Fiaschetti; John D McCann; Robert A Goldberg
Journal:  Am J Ophthalmol       Date:  2005-01       Impact factor: 5.258

6.  Eyelid tumors: histopathological and clinical study performed in County Hospital of Oradea between 2000-2007.

Authors:  Mihaela Cristiana Coroi; Elena Roşca; Gabriela Muţiu; T Coroi; Marinela Bonta
Journal:  Rom J Morphol Embryol       Date:  2010       Impact factor: 1.033

7.  Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota.

Authors:  B E Cook; G B Bartley
Journal:  Ophthalmology       Date:  1999-04       Impact factor: 12.079

8.  Pattern of orbital exenteration in a tertiary eye care centre in India.

Authors:  Neelam Pushker; Seema Kashyap; Ramamurthy Balasubramanya; Mandeep S Bajaj; Seema Sen; Subhash M Betharia; Supriyo Ghose
Journal:  Clin Exp Ophthalmol       Date:  2004-02       Impact factor: 4.207

9.  Surgical approaches used in the reconstruction of the eyelids after excision of malignant tumors.

Authors:  Kaan Gündüz; Sibel Demirel; Ilhan Günalp; Burcu Polat
Journal:  Ann Ophthalmol (Skokie)       Date:  2006

Review 10.  Pathology of eyelid tumors.

Authors:  Jacob Pe'er
Journal:  Indian J Ophthalmol       Date:  2016-03       Impact factor: 1.848

View more
  1 in total

1.  Eyelid carcinomas: Tumor aggressiveness tendencies for smokers compared to non-smokers.

Authors:  Razvan Mercut; Irina Maria Mercut; Adina Dorina Glodeanu; Mihaela Ionescu; Adina Turcu; Alin Stefanescu-Dima; Marius Eugen Ciurea
Journal:  Exp Ther Med       Date:  2022-01-21       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.